Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism

The adverse metabolic effects of prescribed and endogenous glucocorticoid excess, ‘Cushing’s syndrome’, create a significant health burden. While skeletal muscle atrophy and resultant myopathy is a clinical feature, the molecular mechanisms underpinning these changes are not fully defined. We have c...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Endocrinol
Auteurs principaux: Morgan, Stuart A, Hassan-Smith, Zaki K, Doig, Craig L, Sherlock, Mark, Stewart, Paul M, Lavery, Gareth G
Format: Artigo
Langue:Inglês
Publié: Bioscientifica Ltd 2016
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5064767/
https://ncbi.nlm.nih.gov/pubmed/27048233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/JOE-16-0011
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires